BioMark is VC-Backed and has raised funding across M&A - PATHOLOGY ASIA and Seed rounds. It is backed by Pah Tech.
Alternatives.pe tracks BioMark's funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Browse all uploaded documents here
FY 2025
Extracted Financial Statement
ViewExtracted Financial Statement 2024
Extracted Financial Statement
ViewExtracted Financial Statement 2023
Extracted Financial Statement
ViewExtracted Financial Statement 2022
Extracted Financial Statement
ViewExtracted Financial Statement 2021
Extracted Financial Statement
ViewExplore the latest updates and insights
Pathology Asia Completes Acquisition of BioMark for SGD 2.72 Million
Acquisition event
A view of the number of employees over time
Key members of the management team